Resistance to Targeted Therapies in Lymphomas

Du sparer 0% ift. normalprisen Spar 0%

Hardback
8-11 hverdage
1.116,95 kr.

Bag om Resistance to Targeted Therapies in Lymphomas

Over the past few decades, lymphoma patient outcomes have improved as a result of multidrug chemotherapy and radiation therapy, intensification of treatment, improvement in supportive care, and better imaging and staging systems.

Vis mere

Sprog:
Engelsk

ISBN:
9783030244231

Forlag:
Springer Nature Switzerland AG

Indbinding:
Hardback

Sideantal:
210

Udgivet:
30. september 2019

Udgave:
12019

Størrelse:
155x235x0 mm.

Vægt:
518 g.

Leveringstid: 8-11 hverdage.
Forventet levering: 13. december 2024

På lager

Forlænget returret til d. 31. januar 2025

Normalpris

BLACK WEEK
1.116,95 kr. + Fragt
~~1.116,95 kr.~~

Medlemspris

1.066,95 kr.

Prøv i 30 dage for 45 kr.
Herefter fra 79 kr./md. Ingen binding.

Beskrivelse af Resistance to Targeted Therapies in Lymphomas

Over the past few decades, lymphoma patient outcomes have improved as a result of multidrug chemotherapy and radiation therapy, intensification of treatment, improvement in supportive care, and better imaging and staging systems.

Brugerbedømmelser af Resistance to Targeted Therapies in Lymphomas

Andre købte også..

Find lignende bøger

Bogen Resistance to Targeted Therapies in Lymphomas findes i følgende kategorier:

Business og læring

Resistance to Targeted Therapies in Lymphomas - Bog

Beskrivelse af Resistance to Targeted Therapies in Lymphomas

Brugerbedømmelser af Resistance to Targeted Therapies in Lymphomas

Gør som tusindvis af andre bogelskere